The findings show that the risk associated with many of these events is greater than that of stroke - a known risk of atrial fibrillation - prompting the researchers to call for interventions to reduce the risk of non-stroke outcomes in adults with the condition.
It is already known that atrial fibrillation or irregular heartbeat is associated with an increased risk of stroke and death, as well as higher medical costs and a reduced quality of life, researchers said.
Researchers based at the University of Oxford in the UK and the Massachusetts Institute of Technology in the US set out to quantify the associations between atrial fibrillation and cardiovascular disease, renal (kidney) disease, and death.
They analysed the results of 104 studies involving over nine million participants (587,867 with atrial fibrillation). Differences in study design and quality were taken into account to minimise bias.
Also Read
Atrial fibrillation was associated with an increased risk of a range of different outcomes, including all cause mortality, ischaemic heart disease, chronic kidney disease, heart failure, and sudden cardiac death, researchers found.
The absolute risk increase for heart failure (11 events per 1,000 participant years) was the highest among the outcomes examined, researchers said.
Atrial fibrillation was also associated with a twofold risk of cardiovascular mortality, a 2.3-fold risk of stroke, and a fivefold risk of incident congestive heart failure.
Further analyses to test the strength of the associations between atrial fibrillation and these outcomes were broadly consistent, suggesting that the results are robust.
"Our study could have implications for the prioritisation of public health resources and the development of novel interventions for adults with atrial fibrillation," they said.
Disclaimer: No Business Standard Journalist was involved in creation of this content